Prothrombin and factor X are elevated in multiple sclerosis patients

Animal models have implicated an integral role for coagulation factors in neuroinflammatory diseases such as multiple sclerosis (MS) beyond their role in hemostasis. However, their relevance in humans requires further elucidation. This study aimed to determine whether levels of coagulation factors differ between patients with neuroimmunological disorders and respective controls. Individuals suffering from relapsing–remitting and secondary progressive MS had significantly higher prothrombin and factor X levels than healthy donors, whereas levels were unchanged in primary progressive MS and neuromyelitis optica patients. Our study demonstrates that coagulation factors may be key mediators in neuroinflammation and may therefore provide future targets for therapeutic strategies. Ann Neurol 2016;80:946–951

[1]  C. Ruppert,et al.  Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells , 2016, Nature Communications.

[2]  M. Trojano,et al.  Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration , 2014, PloS one.

[3]  R. Tsien,et al.  Early detection of thrombin activity in neuroinflammatory disease , 2014, Annals of neurology.

[4]  D. Arnold,et al.  Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? , 2012, Acta Neuropathologica.

[5]  D. Davalos,et al.  Fibrinogen as a key regulator of inflammation in disease , 2011, Seminars in Immunopathology.

[6]  A. Lutterotti,et al.  Fibrinogen is not elevated in the cerebrospinal fluid of patients with multiple sclerosis , 2011, Fluids and Barriers of the CNS.

[7]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[8]  T. Renné,et al.  In vivo roles of factor XII. , 2010, Blood.

[9]  E. Conway,et al.  Coagulation and innate immune responses: can we view them separately? , 2009, Blood.

[10]  Sevki Sahin,et al.  Coagulation status and biochemical and inflammatory markers in multiple sclerosis , 2008, Journal of Clinical Neuroscience.

[11]  Sergio E. Baranzini,et al.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets , 2008, Nature.

[12]  H. Lassmann,et al.  The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease , 2007, The Journal of experimental medicine.

[13]  M. Pepys,et al.  Human plasma fibrinogen is synthesized in the liver. , 2007, Blood.

[14]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[15]  Benjamin D. Sachs,et al.  Fibrin mechanisms and functions in nervous system pathology. , 2004, Molecular interventions.

[16]  M. Cuzner,et al.  Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors. , 2003, Brain : a journal of neurology.

[17]  J. Paramo.  The hemostatic system as a modulator of atherosclerosis. , 2011, The New England journal of medicine.

[18]  L. Steinman,et al.  Innate and Adaptive Autoimmunity Directed to the Central Nervous System , 2009, Neuron.

[19]  P. Reitsma,et al.  Blood coagulation factors as inflammatory mediators. , 2005, Blood cells, molecules & diseases.

[20]  S. Strukova.  Thrombin as a Regulator of Inflammation and Reparative Processes in Tissues , 2004, Biochemistry (Moscow).

[21]  Strukova Sm.  Thrombin as a Regulator of Inflammation and Reparative Processes in Tissues , 2001 .